Media Coverage

Ceva gets authorization for combination vaccine

May 17, 2017 - Animal Pharm
By Joseph Harvey
Animal Pharm
May 17, 2017

Vaccines in combination against infectious bronchitis virus (IBV) in chickens.

Together, these two vaccines offer nine weeks of immunity against IBV for broilers and layers. Ceva pointed out this timeframe is crucial, as up to 40% of broilers are now reared for 8-9 weeks.

The French firm said evolving consumer demand "for more taste from ethically-reared birds" has prompted poultry producers to adapt the way they rear their birds. Ceva said combined vaccination will simplify programs for layer pullets with less re-vaccination required during the rearing period.

Ceva's combination spray vaccine is also able to reduce the virus load in the trachea. The company's head of poultry marketing, Dr Pascal Paulet, explained: "Achieving simple disease protection through vaccination is no longer enough, the new standard means that today's vaccines must also be capable of reducing overall disease pressure by minimizing circulation of field viruses."

The new claims for the IBV vaccines give added weight to the firm's Cevac portfolio, which is being used to tackle IBV globally. Earlier this year, Ceva's US business launched a new live monovalent poultry vaccine – Cevac IBron – to combat the Georgia strains of IBV in poultry.

Cevac vaccines are also being used to tackle avian influenza in countries such as Mexico.

Reprinted with permission of Animal Pharm News




News Releases

Inside the Corridor

KC Animal Health Blog

Investment Forum